Ireland Teams with WHO to Participate in Solidarity Trial & Allocates €2.4m to Support Hospitals Patient Recruitment Costs

Ireland Teams with WHO to Participate in Solidarity Trial & Allocates €2.4m to Support Hospital Patient Recruitment Costs

The Irish government recently signed up to participate in a World Health Organization (WHO) research collaboration, which will lead to more Irish COVID-19 patient participation in international clinical trials. Ireland joins the Solidarity Trial. With this announcement comes €2.4 million in funding to support hospitals in their need to recruit patients for the study.


The Solidarity Trial in Ireland is coordinated by the Health Research Board and supported by University College Cork, where principal investigator Professor Joe Eustace reports that six main university-based clinical research facilities, as well as their affiliated hospitals, will serve as research centers for the study nationwide.

The Solidary Trial

This international collaboration involves WHO and member states to investigate possible COVID-19 treatments. Thus far, they have recruited 5,000 participants to date across 35 counties while another 100 countries are awaiting approval to participate, reports the Irish Times. According to the WHO website, over 3,500 have participated in the Solidarity Trial to date.

Ireland Revs Up Study Startup

Ireland’s study startup apparatus gears up to commence patient recruitment at hospitals across the country, reports the Department of Health. Solidarity evaluates a number of anti-viral and anti-malarial and anti-inflammatory drugs proposed as possible COVID-19 Treatments.

Irish Government Position

Ireland’s Minister for Health, Simon Harris, announced the funding for the study as well as conveyed his delight with Ireland “playing its part” and participating in this study “in solidarity with our international partners.” Although there are no proven treatments, he communicated with confidence WHO’s study that “There are still no proven treatments for COVID-19, and it is really important that any potential treatments are prescribed within the context of clinical trials where patients provide consent and everything is controlled and monitored.” Although there are fewer patients in the hospital with SARS-CoV-2, the trial offers hope for those still ill and hospitalized.

Lead Research/Investigator

Professor Joe Eustace, MD, serves as principal investigator representing the entire nation of Ireland for the Solidarity Trial. Eustace directs the HRB Clinical Research Facility at UCC (CRF-C), serves as Chairman of the HRB CRCI Senior Management Team, and is a Professor of Patient-Focused Research at UCC. He is also a Consultant Renal Physician at Cork University Hospital.

Call to Action: For TrialSite Network members in Ireland that have loved ones hospitalized due to COVID-19, consider looking into the Solidarity Trial coming to Ireland soon.